594 related articles for article (PubMed ID: 25016508)
21. Efficacy of sugammadex for the reversal of moderate and deep rocuronium-induced neuromuscular block in patients pretreated with intravenous magnesium: a randomized controlled trial.
Czarnetzki C; Tassonyi E; Lysakowski C; Elia N; Tramèr MR
Anesthesiology; 2014 Jul; 121(1):59-67. PubMed ID: 24608361
[TBL] [Abstract][Full Text] [Related]
22. Safety and Efficacy of Rocuronium With Sugammadex Reversal Versus Succinylcholine in Outpatient Surgery-A Multicenter, Randomized, Safety Assessor-Blinded Trial.
Soto R; Jahr JS; Pavlin J; Sabo D; Philip BK; Egan TD; Rowe E; de Bie J; Woo T
Am J Ther; 2016; 23(6):e1654-e1662. PubMed ID: 25768376
[TBL] [Abstract][Full Text] [Related]
23. Reversal of rocuronium-induced neuromuscular block with the novel drug sugammadex is equally effective under maintenance anesthesia with propofol or sevoflurane.
Vanacker BF; Vermeyen KM; Struys MM; Rietbergen H; Vandermeersch E; Saldien V; Kalmar AF; Prins ME
Anesth Analg; 2007 Mar; 104(3):563-8. PubMed ID: 17312209
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone does not diminish sugammadex reversal of neuromuscular block - clinical study in surgical patients undergoing general anesthesia.
Rezonja K; Mars T; Jerin A; Kozelj G; Pozar-Lukanovic N; Sostaric M
BMC Anesthesiol; 2016 Oct; 16(1):101. PubMed ID: 27765010
[TBL] [Abstract][Full Text] [Related]
25. Sugammadex, a new reversal agent for neuromuscular block induced by rocuronium in the anaesthetized Rhesus monkey.
de Boer HD; van Egmond J; van de Pol F; Bom A; Booij LH
Br J Anaesth; 2006 Apr; 96(4):473-9. PubMed ID: 16464982
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of sugammadex in the reversal of deep neuromuscular blockade induced by rocuronium in patients with end-stage renal disease: A comparative prospective clinical trial.
de Souza CM; Tardelli MA; Tedesco H; Garcia NN; Caparros MP; Alvarez-Gomez JA; de Oliveira Junior IS
Eur J Anaesthesiol; 2015 Oct; 32(10):681-6. PubMed ID: 26225497
[TBL] [Abstract][Full Text] [Related]
27. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex.
Staals LM; Driessen JJ; Van Egmond J; De Boer HD; Klimek M; Flockton EA; Snoeck MM
Acta Anaesthesiol Scand; 2011 Jul; 55(6):700-7. PubMed ID: 21574968
[TBL] [Abstract][Full Text] [Related]
28. Reversal of neuromuscular block with sugammadex: a comparison of the corrugator supercilii and adductor pollicis muscles in a randomized dose-response study.
Yamamoto S; Yamamoto Y; Kitajima O; Maeda T; Suzuki T
Acta Anaesthesiol Scand; 2015 Aug; 59(7):892-901. PubMed ID: 25962400
[TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in cardiac patients undergoing noncardiac surgery.
Dahl V; Pendeville PE; Hollmann MW; Heier T; Abels EA; Blobner M
Eur J Anaesthesiol; 2009 Oct; 26(10):874-84. PubMed ID: 19455040
[TBL] [Abstract][Full Text] [Related]
30. Reversal of neuromuscular blockade with sugammadex at the reappearance of four twitches to train-of-four stimulation.
Pongrácz A; Szatmári S; Nemes R; Fülesdi B; Tassonyi E
Anesthesiology; 2013 Jul; 119(1):36-42. PubMed ID: 23665915
[TBL] [Abstract][Full Text] [Related]
31. Sugammadex given for rocuronium-induced neuromuscular blockade in infants: a retrospectıve study.
Ozmete O; Bali C; Cok OY; Turk HE; Ozyilkan NB; Civi S; Aribogan A
J Clin Anesth; 2016 Dec; 35():497-501. PubMed ID: 27871583
[TBL] [Abstract][Full Text] [Related]
32. Reversal of profound neuromuscular block by sugammadex administered three minutes after rocuronium: a comparison with spontaneous recovery from succinylcholine.
Lee C; Jahr JS; Candiotti KA; Warriner B; Zornow MH; Naguib M
Anesthesiology; 2009 May; 110(5):1020-5. PubMed ID: 19387176
[TBL] [Abstract][Full Text] [Related]
33. Sugammadex is effective in reversing rocuronium in the presence of antibiotics.
Hudson ME; Rietbergen H; Chelly JE
BMC Anesthesiol; 2014; 14():69. PubMed ID: 25157214
[TBL] [Abstract][Full Text] [Related]
34. Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment.
Panhuizen IF; Gold SJ; Buerkle C; Snoeck MM; Harper NJ; Kaspers MJ; van den Heuvel MW; Hollmann MW
Br J Anaesth; 2015 May; 114(5):777-84. PubMed ID: 25829395
[TBL] [Abstract][Full Text] [Related]
35. Rocuronium and sugammadex in patients with myasthenia gravis undergoing thymectomy.
Sungur Ulke Z; Yavru A; Camci E; Ozkan B; Toker A; Senturk M
Acta Anaesthesiol Scand; 2013 Jul; 57(6):745-8. PubMed ID: 23678983
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
[TBL] [Abstract][Full Text] [Related]
37. Cochrane corner: sugammadex, a selective reversal medication for preventing postoperative residual neuromuscular blockade.
Abrishami A; Ho J; Wong J; Yin L; Chung F
Anesth Analg; 2010 Apr; 110(4):1239. PubMed ID: 20357160
[TBL] [Abstract][Full Text] [Related]
38. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex.
Unterbuchner C; Ziegleder R; Graf B; Metterlein T
Acta Anaesthesiol Scand; 2015 Apr; 59(4):536-40. PubMed ID: 25582520
[TBL] [Abstract][Full Text] [Related]
39. A randomised controlled trial comparing sugammadex and neostigmine at different depths of neuromuscular blockade in patients undergoing laparoscopic surgery.
Geldner G; Niskanen M; Laurila P; Mizikov V; Hübler M; Beck G; Rietbergen H; Nicolayenko E
Anaesthesia; 2012 Sep; 67(9):991-8. PubMed ID: 22698066
[TBL] [Abstract][Full Text] [Related]
40. Sugammadex for the reversal of muscle relaxation in general anaesthesia: a systematic review and economic assessment.
Chambers D; Paulden M; Paton F; Heirs M; Duffy S; Craig D; Hunter J; Wilson J; Sculpher M; Woolacott N
Health Technol Assess; 2010 Jul; 14(39):1-211. PubMed ID: 20688009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
